난소암 3기 진단으로 아바스틴 항암중입니다.. 판독 부탁드려요..!
검사명 : CT Abdomen + Pelvis (GU) (contrast)
[Conclusion]
Interval increased size of LNs retrocaval area (arrow, 1.4cm -> 1.8cm in short diameter)
--> metastasis, probably
No significant interval change of small LNs in left EIA area
--> indeterminate LNs
[Finding]
C.I.> #1. Ovarian Ca
s/p TAH, BSO, omentectomy, peritoneum resection (‘16-05-09)
s/p Taxol/carbo #6 (‘16-06-24~’16-11-04)
s/p Paxel/carbo/avastin (‘18-07~’18-09-04)
on avastin (‘18-12~‘19-11-07) BRCA WNL
on Avastin maintenance #22 (‘20-01-15)***
Compared with 2020-03-11 CT
Tumor marker WNL
Interval increased size of LNs retrocaval area (arrow, 1.4cm -> 1.8cm in short diameter)
--> metastasis, probably
No significant interval change of small LNs in left EIA area
--> indeterminate LNs
No significant chang of mild peritoneal thickening of pelvic cavity.
--> post op change, likely
No evidence of local tumor recurrence at vaginal stump.
No abnormality of the liver, pancreas, spleen, both kidneys, and adrenal glands.
s/p cholecystectomy state.
No hydronephrosis.
No significant ascites.
No osteolytic lesion in axial skeletons.
Refer to chest CT for covered lung base
[Clinical Information]
#1. Ovarian Ca
s/p TAH, BSO, omentectomy, peritoneum resection (‘16-05-09)
s/p Taxol/carbo #6 (‘16-06-24~’16-11-04)
s/p Paxel/carbo/avastin (‘18-07~’18-09-04)
on Avastin maintenance #26 ('20-04-08)***
#2. HTN on med
#3. Cerebral infarction on ASA